maxwellt/fedgrantsembedded huggingface dataset:
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-10 | Closing date: 2026-10-13
Award ceiling: 150000
Cost sharing or matching requirement: No

Through this Notice of Funding Opportunity (NOFO) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this NOFO is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may support the acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay. Research projects proposed for this NOFO encourage multi-disciplinary interaction among scientific investigators, assay developers, clinicians, statisticians, and clinical laboratory staff. Clinical laboratory scientist(s) and statistical experts are highly encouraged to comprise integral parts of the application. This NOFO is not intended to support early-stage development of technology or the conduct of clinical trials, but rather the adaption and validation of assays to the point where they could be integrated into clinical trials as investigational assays/tools/devices.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-10 | Closing date: 2025-09-30
Award ceiling: 300000
Cost sharing or matching requirement: No

GL to update purpose after the NOFO is finalized. Develop plans to establish or enhance BME departments, interdisciplinary technology centers, and/or academic programs which may include: Support research and educational opportunities for trainees in bioengineering and technology development (Undergrad and/or Graduate) Plans for core technology facilities, maker space, data science centers Faculty recruitment, collaborative research programs, training, and partnerships Building curriculum and course development Innovation and entrepreneurship programs Plans for sustainability of programs

Eligibility: Other Eligible Applicants include the following:  Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.   See full Notice of Funding Opportunity for additional information on eligibility.
U.S. Embassy in Finland Public Diplomacy Annual Program Statement
Agency: U.S. Mission to Finland
Posted: 2023-10-11 | Closing date: 2024-07-31
Proposals will be considered on a rolling basis until July 31, 2024
Award ceiling: 50000
Award floor: 5000
Expected number of awards: 10
Cost sharing or matching requirement: No

 Description: The Public Diplomacy Section (PDS) of the U.S. Embassy in Finland, U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Grants Program. This is an Annual Program Statement, outlining our funding priorities, the strategic themes we focus on, and the procedures for submitting requests for funding. Please carefully follow all instructions below.  PDS Finland invites proposals for programs that promote bilateral cooperation and highlight shared values. All programs must include an American perspective, societal or cultural element, or connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and viewpoints. A confirmed local Finnish organization (or partnering organization) must be identified in the grant application. Additionally, programs must include a public outreach component(s), such as livestreaming, masterclasses, traditional media, digital outreach, or events open to audiences. Examples of PDS Grants Program projects include, but are not limited to: Artistic and cultural workshops, joint performances, and exhibitions; Academic and professional lectures, and seminars; Professional and academic exchanges and programs Priority Program Areas: Proposals that relate to the Arctic and increasing cooperation between Arctic states and communities; Addressing climate change and changing environmental conditions; Proposals that advance diversity, equity, inclusion, and accessibility (DEIA); Proposals that address global security challenges and increasing understanding of NATO, including programs in support of Women, Peace, and Security (WPS) initiatives; Proposals that increase collaboration and exchange between American and Finnish students and teachers; Proposals that promote economic prosperity, entrepreneurship, and innovation; Proposals that counter disinformation  The following types of programs are not eligible for funding: Programs relating to partisan political activities; Charitable or development activities; Construction programs; Fund-raising campaigns; Lobbying for specific legislation; Programs intended primarily for the growth or institutional development of the organization; Programs intended for an individual’s personal enrichment or career development; Programs that do not include an organization based in Finland; Grants to for-profit entities 

Public Diplomacy
RFA-DD-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-13 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 10
Cost sharing or matching requirement: No

Submit application as necessary.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,  .
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
Agency: National Institutes of Health
Posted: 2023-10-12 | Closing date: 2027-01-06
Cost sharing or matching requirement: No

The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative and interdisciplinary research teams focused on clinical, health services, and/or community-based interventions that address health and healthcare disparities related to non-communicable and chronic diseases (NCDs) with the highest burden and mortality in Latin America and among U.S. Hispanics/Latinos. Multidisciplinary research teams would be expected to meaningfully collaborate with key partners that must include at least one PI or MPI from institutions in Latin America.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-12 | Closing date: 2027-01-06
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) will support innovative, collaborative, and multi-disciplinary research focused on clinical epidemiology, evaluation of public and/or health care policies, and validation of measurements that address health and health care disparities related to non-communicable and chronic diseases (NCDs) with the highest disease burden and mortality in Latin America and among U.S. Hispanics/Latinos. Multi-disciplinary research teams would be expected to meaningfully collaborate with key partners that must include at least one PI or MPI from institutions in Latin America.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
RFA-GH-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-13 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-10-16 | Closing date: 2024-12-04
Cost sharing or matching requirement: No

Through this Notice of Funding Opportunity Announcement (NOFO), the National Cancer Institute (NCI) intends to expand the research scope and leverage the gains made through the NOFO entitled Investigation of the Transmission of KSHV (RFA-CA-18-013 and RFA-CA-20-046) to support basic and translational research that will guide the development of a prophylactic or therapeutic Kaposi sarcoma herpesvirus (KSHV) vaccine. A prophylactic KSHV vaccine could prevent primary KSHV infection, transmission, and subsequent development of KS and other KSHV-associated syndromes such as multicentric Castleman disease (MCD), primary effusion lymphoma (PEL) and KSHV inflammatory cytokine syndrome (KICS) or ameliorate the severity of disease. A therapeutic KSHV vaccine could be helpful in preventing or treating KSHV disease in people who are already infected with KSHV. Research areas could include, but are not limited to: (1) Identification and evaluation of KSHV structural and non-structural targets for a potential KSHV vaccine; (2) Development of animal models to study a prototype KSHV vaccine or vaccines; (3) Development and testing of a candidate KSHV vaccine or vaccines; (4) Studies to assess how the efficacy of a promising KSHV vaccine can be optimized for PWH; (5) Research to better define the initial steps of infection with KSHV and the primary means of person-to-person transmission in different populations that can be targeted with a vaccine; and (6) Optimization and/or standardization of KSHV detection methods.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-17 | Closing date: 2024-11-20
Award ceiling: 275000
Cost sharing or matching requirement: No

The purpose of this notice of funding opportunity (NOFO) is to support research projects that aim to further understanding of the developmental trajectories of late talking children by leveraging existing data and creating open and shared data resources to aid in identifying patterns and predictors of developmental outcomes in late talking children, and exploring potential underlying mechanisms, risk factors, and sequalae.

Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-17 | Closing date: 2025-03-13
Award ceiling: 500000
Cost sharing or matching requirement: No

The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
F24AS00431 FY24 Recovery Implementation
Agency: Fish and Wildlife Service
Posted: 2023-10-18 | Closing date: 2024-09-30
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. Applicants seeking financial assistance for Recovery Implementation projects are requested to consult with their local Ecological Services Field or Regional Office before developing or submitting an application (See Section H).  Because the amount of funding available and the timing of funding dates varies by region, funding is not available throughout the year in every region. Coordination will ensure project proponents are up-to-date on whether funding may be available and the specific timing of regional review.
Estimated total program funding: 14000000
Award ceiling: 2000000
Award floor: 1000
Cost sharing or matching requirement: No

Consolidated Appropriations Act, 2022— Administrative Provisions (Pub. L. 117-103 [H.R. 2471—305]), Endangered Species Act, 16 U.S.C. §1531 et. seq.The principal objective of this Recovery Implementation funding opportunity is to support the implementation of priority recovery actions for federally endangered and threatened species. The ESA conveys the importance of recovery plans as a central organizing tool for guiding each species recovery process by requiring their development for every listed species. Recovery plans establish an overall recovery vision that, among other things: • Defines the point at which protections under the Endangered Species Act (ESA) are no longer needed, • Identifies and prioritizes the most effective and feasible suite of recovery actions that will promote species survival and recovery, • Provides the public and policy makers with an overall estimate of the time and cost to recover species, and the ability to measure success and resources needs, and • Aids the Service in working with others to improve the status for imperiled species.

Eligibility: Applicants are expected to have demonstrated knowledge and understanding of the biology of the involved endangered or threatened species and their ecosystem, including preferably having worked with the species and holding a currently valid Endangered Species Act permit, issued by the Service, authorizing them to work with these species (or that have previously held a permit to do so). If funding is awarded, applicants that do not currently hold a valid permit for the proposed activity may need to apply for and obtain a Service permit before beginning the proposed activity. For more information about the permit requirements, please visit our Ecological Services Program’s permit website at https://fws.gov/service/permitsThe applicant’s participation as a CESU member must be verified by reviewing the current regional CESU agreement found at http://www.cesu.psu.edu/ if the applicant is requesting the use of the CESU 17.5% indirect rate. These awards must be issued as Cooperative Agreements.
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-17 | Closing date: 2025-03-13
Award ceiling: 275000
Cost sharing or matching requirement: No

The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
RFA-TS-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-19 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

 Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-SH-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-19 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

 Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
FY2024 Development Innovation Ventures_APS
Agency: Agency for International Development
Posted: 2023-10-20 | Closing date: 2024-11-01
Award ceiling: 15000000
Award floor: 25000
Cost sharing or matching requirement: No

Pursuant to the Foreign Assistance Act of 1961, as amended, the United States Government, as represented by the U.S. Agency for International Development (USAID), invites applications for the Development Innovation Ventures (DIV) program.The purpose of this APS is to disseminate information to prospective applicants so they may develop and submit applications for USAID funding. This APS: (A) describes the types of activities for which applications will be considered; (B) describes the funding available and the process and requirements for submitting applications; (C) explains the criteria for evaluating applications; and (D) refers prospective applicants to relevant documentation available on the internet. USAID anticipates awarding multiple grants as a result of this APS. To be competitive under this solicitation, applications must be fully responsive to all directions within this APS document. Note that USAID may not award to an applicant unless the applicant has complied with all applicable System for Award Management (SAM) requirements detailed in Section D. Applicants may submit an initial application prior to registering on SAM.gov, but the registration process may take many weeks to complete, and, therefore, applicants should begin registration as soon as possible.

Eligibility: See Section C Eligibility Information.
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-10-19 | Closing date: 2024-10-23
Award ceiling: 750000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases within the NIDDK's mission. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission ofthe NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
RFA-PS-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

 Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-10-19 | Closing date: 2027-01-07
Cost sharing or matching requirement: No

The purpose of this Notice of Funding Opportunity (NOFO) is to support multidisciplinary and innovative intervention research to understand and address maternal morbidity and mortality in the United States, particularly but not exclusively among racial and ethnic minority, socioeconomically disadvantaged, and underserved rural populations, with a focus on understudied healthcare factors. This is a new funding opportunity to advance the goals of the NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative. IMPROVE aims to understand the biological, behavioral, environmental, sociocultural, clinical, and structural factors that affect pregnancy-related and pregnancy-associated severe morbidity and mortality and build an evidence base for improved care and outcomes. The IMPROVE initiative supports research to reduce preventable causes of maternal deaths and improve health for women before, during, and after delivery. It includes a special emphasis on health disparities and populations that are disproportionately affected, such as racial and ethnic minority persons, very young women and women of advanced maternal age, and people with disabilities.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
RFA-IP-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
Agency: National Institutes of Health
Posted: 2023-10-19 | Closing date: 2024-06-13
Award ceiling: 6700000
Cost sharing or matching requirement: No

This RFA will solicit applications for a pivotal phase 3 clinical trial to determine the efficacy of FDA approved monoclonal antibody therapy compared to placebo in diverse "mixed dementia" populations with a focus on vascular contributions. Mixed dementia refers to dementia cases positive for 1) Alzheimer biomarkers, such as amyloid positron emission tomography and/or low cerebrospinal fluid amyloid beta 42 combined with elevated phosphorylated tau; and 2) evidence of vascular contributions based on imaging (white matter disease and/or subclinical infarction). Bayesian approaches with response adaptive randomization to examine specific subgroups are engouraged. Successful applications will be well-powered to determine efficacy in diverse populations representative of the effect of the disease in the United States by sex, race/ethnicity, and geographic distribution. Applications must include patient and community engagement cores that are incorporated into all stages of program development and at all levels of the organizational structure.

Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-10-20 | Closing date: 2024-11-19
Award ceiling: 275000
Cost sharing or matching requirement: No

The National Institutes of Health (NIH) Tackling Acquisition of Language in Kids (TALK) initiative seeks to support activities to better understand early language learning and delay. NIH TALK invites applications for research projects that aim to better understand the information and practice needs of caregivers, professionals, and other invested parties who support late talking children and to determine whether those needs are being effectively met. Community engaged research combined with rigorous qualitative research and diverse perspectives is needed to enrich our understanding of how to get state-of-the-science information and practice to those who need it most to guide decisions about late talking children.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
RFA-CC-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-TP-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-OT-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-CD-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-DP-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-CK-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-EH-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

 Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
RFA-CE-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
Agency: National Institutes of Health
Posted: 2023-10-20 | Closing date: 2026-10-27
Cost sharing or matching requirement: No

he NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting well designed and well executed clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between an NIDCD Project Scientist and an investigator to support a clinical trial that meets ANY of the following criteria: requires FDA oversight, is intended to formally establish efficacy, or has a higher risk to potentially cause physical or psychological harm.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
RFA-OE-18-000
Agency: Centers for Disease Control and Prevention - ERA
Posted: 2023-10-20 | Closing date: 2025-10-13
Estimated total program funding: 0
Award ceiling: 0
Award floor: 0
Expected number of awards: 100
Cost sharing or matching requirement: No

Submit application as necessary for Type 6 Applications.

Eligibility: States, Universities, County, Small Business, Non-Profits Organization,
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
Agency: National Institutes of Health
Posted: 2023-10-20 | Closing date: 2028-01-07
Award ceiling: 500000
Cost sharing or matching requirement: No

The NIDCD is committed to identifying effective interventions for the diagnosis, prevention, or treatment of communication disorders by supporting well-designed and well-executed clinical trials. This funding opportunity announcement (FOA) supports investigator initiated low risk clinical trials addressing the mission and research interests of NIDCD. Clinical trials must meet ALL the following criteria: meet the budget limits of this FOA, not require FDA oversight, are not intended to formally establish efficacy and have low risks to potentially cause physical or psychological harm.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
U.S. Consulate General Hong Kong and Macau, PAS
Agency: U.S. Mission to China
Posted: 2023-10-24 | Closing date: 2024-08-23
Estimated total program funding: 300000
Award ceiling: 50000
Award floor: 200
Expected number of awards: 40
Cost sharing or matching requirement: No

PAS Hong Kong and Macau invites proposals for programs that strengthen cultural ties between the United States and Hong Kong and the United States and Macau through cultural and exchange programming that highlights shared values and promotes bilateral cooperation. All programs must include a U.S. element or connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives and build partnerships. 

Eligibility: • registered not-for-profit organizations, including think tanks and civil society/non-governmental organizations with programming experience;  • individuals;  • non-profit or governmental educational institutions; and  • governmental institutions.
• Programs that support STEAM-related activities.  • Programs that promote English language acquisition.  • Programs that promote economic empowerment, with a priority for under-represented communities.  • Programs that increase public awareness about the environment, sustainability, climate change, and conservation efforts.  • Programs and exchanges that facilitate academic and cultural engagements that highlight and/or discuss American expertise, experience and values, and universal human rights.
2023-2026 Accelerated Innovation Deployment (AID) Demonstration
Agency: DOT Federal Highway Administration 
Posted: 2023-10-24 | Closing date: 2026-05-26
The FY 23 application cycle opens October 24, 2023, with a notice of intent deadline of December 12, 2023, and a closing deadline of January 23, 2024. The FY 24* application cycle opens February 27, 2024, with a notice of intent deadline of April 16, 2024, and a closing deadline of May 28, 2024. The FY 25 application cycle opens February 25, 2025, with a notice of intent deadline of April 15, 2025, and a closing deadline of May 27, 2025. The FY 26 application cycle opens February 24, 2026, with a notice of intent deadline of April 14, 2026, and a closing deadline of May 26, 2026.  This is a multiyear funding opportunity; the Key Dates are listed in Attachment A, Key Dates of this notice.
Estimated total program funding: 47500000
Award ceiling: 1000000
Award floor: 100000
Expected number of awards: 40
Cost sharing or matching requirement: Yes

The FHWA continues the Accelerated Innovation Deployment (AID) Demonstration established under 23 United States Code (U.S.C.) 503(c) within the Technology and Innovation Deployment Program (TIDP) to implement accelerated innovation deployment. The AID Demonstration provides incentive funding for any project activities eligible for assistance under title 23, U.S.C. in any phase of a highway transportation project between project planning and project delivery, including planning, financing, operation, structures, materials, pavements, environment, and construction that address the TIDP goals. This Notice of Funding Opportunity (693JJ324NF-AIDDP) requests grant applications during the identified solicitation period, provides selection criteria, lists application requirements, and describes the evaluation process. This is a multiyear funding opportunity; please see the Key Dates - Attachment A of this notice for deadlines. 

Eligibility: Entities eligible to apply are State departments of transportation (State DOT), Federal Land Management Agencies (FLMA), and Tribal governments. Consistent with other FHWA funding provided to tribes, federally recognized tribes identified on the list of “Indian Entities Recognized and Eligible to Receive Services from the Bureau of Indian Affairs” (87 FR 4636) are eligible to apply. Metropolitan planning organizations and local governments must apply through the State DOT as a subrecipient.
U.S. Embassy Tokyo PAS Annual Program Statement
Agency: U.S. Mission to Japan
Posted: 2023-10-25 | Closing date: 2024-09-30
Estimated total program funding: 400000
Award ceiling: 100000
Award floor: 10000
Expected number of awards: 5
Cost sharing or matching requirement: No

U.S. DEPARTMENT OF STATEU.S. EMBASSY TOKYO, PUBLIC AFFAIRS SECTIONNotice of Funding Opportunity (NOFO)Funding Opportunity Title: U.S. Embassy Tokyo PAS Annual Program StatementFunding Opportunity Number: PAS-Tokyo-FY24-APS01Deadline for Applications: September 30, 2024 (11:59 p.m. Japan Standard Time)CFDA Number: 19.040 – Public Diplomacy ProgramsTotal Amount Available: $400,000Maximum for Each Award: $100,000The U.S. Embassy Tokyo Public Affairs Section (PAS) of the U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Small Grants Program. This is an Annual Program Statement, outlining our funding priorities, the strategic themes we focus on, and the procedures for submitting requests for funding. Please see the full notice in the Related Documents folder and carefully follow all instructions. Purpose of Small Grants: PAS Tokyo invites proposals for programs that strengthen cultural ties between the U.S. and Japan through cultural and exchange programming that highlights shared values and promotes bilateral cooperation. All programs must include an American cultural element, or connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives.

Eligibility: Registered not-for-profit organizations, including think tanks and civil society/non-governmental organizations with programming experience.
Public Diplomacy Programs
RESTORE Act Direct Component – Construction and Real Property Acquisition Activities
Agency: U.S. Dept. of Treasury RESTORE Act Program
Posted: 2023-10-26 | Closing date: 2024-10-31
Award ceiling: 110099450
Award floor: 0
Expected number of awards: 10
Cost sharing or matching requirement: No

Treasury is publishing multiple funding opportunity announcements (FOAs) for its RESTORE Act grant programs. This announcement applies only to the Direct Component and is only for applications for eligible construction and real property acquisition activities, including environmental restoration projects and including projects with or without a non-federal cost-share for another federally funded project or program. To apply for eligible activities that do not involve any construction, land acquisition, or environmental restoration, applicants should use the non-construction funding opportunity announcement (GR-RDC-23-001). All construction and real property acquisition activities, and any activity that requires a permit from a federal or state agency, including natural resource restoration projects, should be submitted under this construction and real property acquisition funding opportunity announcement. Trust Fund amounts are available to carry out eligible activities described in the RESTORE Act and Treasury’s implementing regulations at 31 CFR 34.201. These are: 1) Restoration and protection of the natural resources, ecosystems, fisheries, marine and wildlife habitats, beaches and coastal wetlands of the Gulf Coast region. 2) Mitigation of damage to fish, wildlife, and natural resources.3) Implementation of a Federally- approved marine, coastal, or comprehensive conservation management plan, including fisheries monitoring.4) Workforce development and job creation. 5) Improvements to or on State parks located in coastal areas affected by the Deepwater Horizon oil spill.6) Infrastructure projects benefitting the economy or ecological resources, including port infrastructure. 7) Coastal flood protection and related infrastructure.8) Promotion of tourism in the Gulf Coast region, including promotion of recreational fishing.9) Promotion of the consumption of seafood harvested from the Gulf Coast region. 10) Planning assistance.11) Administrative costs. Eligible activities 1 through 7 listed above must be carried out in the Gulf Coast region.

RESTORE Act
RESTORE Act Direct Component - Non-Construction Activities
Agency: U.S. Dept. of Treasury RESTORE Act Program
Posted: 2023-10-26 | Closing date: 2024-10-31
Award ceiling: 110099450
Award floor: 0
Expected number of awards: 10
Cost sharing or matching requirement: No

Treasury is publishing multiple funding opportunity announcements (FOAs) for its RESTORE Act grant programs. This announcement applies only to the Direct Component and is only for applications for eligible non-construction activities, including projects with or without a non-federal cost-share for another federally funded project or program. This announcement also includes planning assistance needed to prepare the Multiyear Implementation Plan (Multiyear Plan) required by the RESTORE Act. To apply for eligible activities involving construction and/or acquisition of real property or any other activity that requires a permit from a federal or state agency, including natural resource restoration projects, applicants should use the construction and real property acquisition funding opportunity announcement (GR-RDC-23-002).Trust Fund amounts are available to carry out eligible activities described in the RESTORE Act and Treasury’s implementing regulations at 31 CFR 34.201. These are: 1) Restoration and protection of the natural resources, ecosystems, fisheries, marine and wildlife habitats, beaches and coastal wetlands of the Gulf Coast region. 2) Mitigation of damage to fish, wildlife, and natural resources.3) Implementation of a Federally- approved marine, coastal, or comprehensive conservation management plan, including fisheries monitoring.4) Workforce development and job creation. 5) Improvements to or on State parks located in coastal areas affected by the Deepwater Horizon oil spill.6) Infrastructure projects benefitting the economy or ecological resources, including port infrastructure. 7) Coastal flood protection and related infrastructure.8) Promotion of tourism in the Gulf Coast region, including promotion of recreational fishing.9) Promotion of the consumption of seafood harvested from the Gulf Coast region. 10) Planning assistance.11) Administrative costs. Eligible activities 1 through 7 listed above must be carried out in the Gulf Coast region.

RESTORE Act